Quantum量子訊息有限公司

Placental Stem Cell Therapy for Neurological Disorders Market

完整報告名稱與涵蓋範圍
Placental Stem Cell Therapy for Neurological Disorders Market Size, Share & Trends Analysis Report By Type (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), By End-User), By Region, And By Segment Forecasts, 2023-2031.

報告摘要

Valued at USD 384.09 Mn as of 2022, the global Placental Stem Cell Therapy for Neurological Disorders Market is forecasted to climb to USD 2,049.44 Mn by 2031, reflecting a compound annual growth rate of 20.6% over the 2023–2031 period. At its core, Placental Stem Cell Therapy for Neurological Disorders pertains to using stem cells derived from the placenta to treat various conditions affecting the nervous system. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands. The market's upward path is supported by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Placental Stem Cell Therapy for Neurological Disorders Market Snapshot Chapter 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis 5.1. By Type, & Market Share, 2020 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type: 5.2.1. Allogeneic Placental Stem Cell Therapy 5.2.2. Autologous Placental Stem Cell Therapy Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis 6.1. By End-User & Market Share, 2020 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End-User: 6.2.1. Hospitals & Specialty Clinics 6.2.2. Clinics Research Organizations 6.2.3. Research Institutes & Academics Chapter 7. Placental Stem Cell Therapy for Neurological Disorders Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031 7.1.2. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts By End-User, 2019-2031 7.1.3. North America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) estimates and forecasts by country, 2019-2031 7.2. Europe 7.2.1. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, 2019-2031 7.2.2. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, 2019-2031 7.2.3. Europe Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031 7.3. Asia Pacific 7.3.1. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, 2019-2031 7.3.2. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, 2019-2031 7.3.3. Asia Pacific Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031 7.4. Latin America 7.4.1. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, (US$ Million) 2019-2031 7.4.2. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031 7.4.3. Latin America Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By Type, (US$ Million) 2019-2031 7.5.2. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) By End-User, (US$ Million) 2019-2031 7.5.3. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market revenue (US$ Million) by country, 2019-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Mesoblast Ltd., 8.2.2. Pluristem Therapeutics, 8.2.3. ReNeuron Group, 8.2.4. AthersysInc., 8.2.5. Cordlife India, 8.2.6. LifeCell International Pvt. Ltd, 8.2.7. Cryo-Cell International Inc., 8.2.8. CBR Systems, 8.2.9. Cellularity Inc., Cynata

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們